Trial Profile
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs BAY 949392 (Primary)
- Indications Heart disorders; Inflammation; Myocardial disorders; Sarcoidosis
- Focus Diagnostic use
- 11 Feb 2019 Planned End Date changed from 1 Apr 2020 to 1 Apr 2021.
- 11 Feb 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Apr 2020.
- 31 Aug 2017 Status changed from not yet recruiting to recruiting.